Icotrokinra met all primary endpoints in the studies, demonstrating significant skin clearance and clinical remission.

The gloves were off even earlier than that after Canadian fans loudly booed the entirety of the U.S. national anthem ahead of the American's 3-1 win at the Bell Centre in Montreal. The tournament ...

Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis.

Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated ...

On Monday, Protagonist Therapeutics, Inc. PTGX announced topline results from ANTHEM-UC Phase 2b study of icotrokinra ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...

Protagonist Therapeutics (PTGX) announced topline results from ANTHEM-UC, a Phase 2b study of icotrokinra, the first investigational targeted ...

Johnson & Johnson announced positive topline results from ANTHEM-UC, a Phase 2b study of icotrokinra, the first investigational targeted ...

A man had friends drive him to the hospital after he was hit by a car. Doctors checked him out, then sent him by ambulance to ...

WOODLAND HILLS, Calif., February 26, 2025--(BUSINESS WIRE)--Anthem Blue Cross Foundation, the philanthropic arm of Anthem Blue Cross of California, announced a $300,000 inaugural impact investment ...

Anthem Blue Cross Foundation, the philanthropic arm of Anthem Blue Cross of California, announced a $300,000 inaugural impact investment loan to Burlingame-based Psyched Services. Facilitated by ...

WOODLAND HILLS, Calif., February 26, 2025--(BUSINESS WIRE)--Anthem Blue Cross Foundation, the philanthropic arm of Anthem Blue Cross of California, announced a $300,000 inaugural impact investment ...